India
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 1 237 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 270 (170–390) 22 (14–32)
Mortality (HIV+TB only) 42 (37–48) 3.4 (3–3.9)
Prevalence  (includes HIV+TB) 2 800 (1 900–3 900) 230 (155–319)
Incidence  (includes HIV+TB) 2 200 (2 000–2 400) 176 (159–193)
Incidence (HIV+TB only) 130 (120–140) 10 (9.4–12)
Case detection, all forms (%) 59 (54–66)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 629 589 (53) Relapse 106 463 (37)
Smear-negative 317 616 (27) Treatment after failure 16 400 (6)
Smear-unknown / not done     Treatment after default 64 782 (23)
Extrapulmonary 234 029 (20) Other 96 567 (34)
Other 2 139 (<1)      
Total new 1 183 373   Total retreatment 284 212  
           
Other (history unknown)          
Total new and relapse 1 289 836   Total cases notified 1 467 585  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.2    
Age < 15 12 957 34 467 33 501
Laboratories 2012
Smear (per 100 000 population) 1.1
Culture (per 5 million population) 0.3
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 88   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 90  
Retreatment 75  
TB/HIV 2012 Number (%)
TB patients with known HIV status 821 807 (56)
HIV-positive TB patients 44 063 (5)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 40 537 (92)
HIV-positive TB patients on antiretroviral therapy (ART) 25 790 (59)
HIV-positive people screened for TB 1 324 386  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.9–2.6) 15 (11–19)
MDR-TB cases among notified pulmonary
TB cases
21 000 (18 000–25 000) 43 000 (32 000–54 000)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     55 611
Laboratory-confirmed MDR-TB cases     16 588
Patients started on MDR-TB treatment     14 143
Financing TB control 2013
National TB programme budget (US$ millions) 182
% Funded domestically 37%
% Funded internationally 57%
% Unfunded 6%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data